European Commission 28 July 2026, Commission Implementing Regulation (EU) 2026/1826 of 28 July 2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, amisulbrom, Bacillus amyloliquefaciens strain MBI 600, beflubutamid, clomazone, cyantraniliprole, cyprodinil, daminozide, dichlorprop-P, dimethachlor, fludioxonil, formetanate, fosetyl, isofetamid, metalaxyl, metazachlor, penconazole, phenmedipham, pirimicarb, pyraclostrobin and S-abscisic acid

Also known as

European Union · · · Cited by 1 · 28-07-2026

Official Journal
of the European Union

L series

2026/1826

29.7.2026

COMMISSION IMPLEMENTING REGULATION (EU) 2026/1826

of 28 July 2026

amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, amisulbrom, Bacillus amyloliquefaciens strain MBI 600, beflubutamid, clomazone,

Read the full text

This document is published by eur-lex.europa.eu.

Moonlit adds the citation network (1 references), article-level links and cross-references, which are available to search for free.